| Primary |
| Product Used For Unknown Indication |
64.0% |
| Hypertension |
14.0% |
| Cardiac Disorder |
4.0% |
| Gastrooesophageal Reflux Disease |
4.0% |
| Abdominal Pain Upper |
1.0% |
| Anticoagulant Therapy |
1.0% |
| Blood Pressure Abnormal |
1.0% |
| Breast Cancer |
1.0% |
| Chest Pain |
1.0% |
| Diabetes Mellitus |
1.0% |
| Gastrointestinal Disorder |
1.0% |
| Intentional Overdose |
1.0% |
| Medullary Thyroid Cancer |
1.0% |
| Palpitations |
1.0% |
| Plasma Cell Myeloma |
1.0% |
| Smoking Cessation Therapy |
1.0% |
| Systemic Lupus Erythematosus |
1.0% |
| Type 2 Diabetes Mellitus |
1.0% |
|
| Toxicity To Various Agents |
27.3% |
| Syncope |
12.1% |
| Completed Suicide |
6.1% |
| Sinus Bradycardia |
6.1% |
| Atrioventricular Block Complete |
3.0% |
| Hypertensive Crisis |
3.0% |
| Oedema Peripheral |
3.0% |
| Off Label Use |
3.0% |
| Pain |
3.0% |
| Pain In Extremity |
3.0% |
| Pemphigoid |
3.0% |
| Pneumonia |
3.0% |
| Sleep Apnoea Syndrome |
3.0% |
| Tachycardia |
3.0% |
| Urinary Tract Infection |
3.0% |
| Verbal Abuse |
3.0% |
| Vertigo |
3.0% |
| Visual Field Defect |
3.0% |
| Vitamin D Decreased |
3.0% |
| Vomiting |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
60.9% |
| Hypertension |
19.2% |
| Diabetes Mellitus |
2.6% |
| Gastrooesophageal Reflux Disease |
2.6% |
| Plasma Cell Myeloma |
2.0% |
| Antidepressant Therapy |
1.3% |
| Bipolar Disorder |
1.3% |
| Blood Pressure |
1.3% |
| Polycythaemia Vera |
1.3% |
| Anxiety |
0.7% |
| Blood Cholesterol |
0.7% |
| Blood Cholesterol Increased |
0.7% |
| Cardiac Disorder |
0.7% |
| Depression |
0.7% |
| Dyslipidaemia |
0.7% |
| Heart Rate Irregular |
0.7% |
| Hypercholesterolaemia |
0.7% |
| Ischaemic Stroke |
0.7% |
| Metastatic Malignant Melanoma |
0.7% |
| Migraine |
0.7% |
|
| Toxicity To Various Agents |
16.7% |
| Weight Increased |
10.0% |
| Hypertension |
6.7% |
| Paraesthesia |
6.7% |
| Pneumonia |
6.7% |
| Wrong Drug Administered |
6.7% |
| Alopecia |
3.3% |
| Blood Immunoglobulin G Increased |
3.3% |
| Cardiac Procedure Complication |
3.3% |
| Cutaneous Lupus Erythematosus |
3.3% |
| Dehydration |
3.3% |
| Exposure Via Ingestion |
3.3% |
| Hepatomegaly |
3.3% |
| Left Ventricular Hypertrophy |
3.3% |
| Liver Injury |
3.3% |
| Mycosis Fungoides |
3.3% |
| Nausea |
3.3% |
| Nodal Rhythm |
3.3% |
| Overdose |
3.3% |
| Pancytopenia |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
24.3% |
| Plasma Cell Myeloma |
15.2% |
| Type 2 Diabetes Mellitus |
8.3% |
| Hypertension |
6.5% |
| Osteoporosis |
6.5% |
| Chronic Myeloid Leukaemia |
6.2% |
| Multiple Sclerosis |
5.4% |
| Hepatitis C |
4.0% |
| Actinic Keratosis |
3.3% |
| Gait Disturbance |
2.9% |
| Myelodysplastic Syndrome |
2.9% |
| Atrial Fibrillation |
2.2% |
| Peripheral T-cell Lymphoma Unspecified |
1.8% |
| Prostate Cancer Metastatic |
1.8% |
| Blood Cholesterol Increased |
1.4% |
| Breast Cancer |
1.4% |
| Colonoscopy |
1.4% |
| Colorectal Cancer Metastatic |
1.4% |
| Diabetes Mellitus |
1.4% |
| Immunodeficiency Common Variable |
1.4% |
|
| Vomiting |
13.8% |
| Nausea |
7.3% |
| Weight Decreased |
6.4% |
| Rash |
5.5% |
| Renal Failure Acute |
5.5% |
| Tremor |
5.5% |
| Deep Vein Thrombosis |
4.6% |
| Fatigue |
4.6% |
| Pancreatitis |
4.6% |
| Renal Failure |
4.6% |
| White Blood Cell Count Decreased |
4.6% |
| Headache |
3.7% |
| Hypotension |
3.7% |
| Off Label Use |
3.7% |
| Renal Impairment |
3.7% |
| Sinus Bradycardia |
3.7% |
| Stress Fracture |
3.7% |
| Swelling Face |
3.7% |
| Thrombocytopenia |
3.7% |
| Urinary Tract Infection |
3.7% |
|
